Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF
( DrugBank: Methotrexate, Tacrolimus, Busulfan, Fludarabine, Fludarabine phosphate / KEGG DRUG: Methotrexate, Methotrexate sodium, Tacrolimus, Tacrolimus, Busulfan, Fludarabine phosphate, Fludarabine, Fludarabine phosphate, Fludarabine )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 60 | Aplastic anemia | 1 |
60. Aplastic anemia
Clinical trials : 357 / Drugs : 477 - (DrugBank : 94) / Drug target genes : 57 - Drug target pathways : 184
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
